|
Market Closed -
Nasdaq
16:00:00 2026-10-02 EDT
|
5-day change | 1st Jan Change | ||
| 735.20 USD | +0.05% |
|
-6.71% | -4.75% |
| 10-02 | Jefferies Raises Regeneron Pharmaceuticals Price Target to $930 From $870, Maintains Buy Rating | MT |
| 10-02 | Major drugmakers turn to China for licensing deals | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| REGENERON PHARMACEUTICALS, INC. | Biopharmaceuticals | +0.05% | -6.71% | -4.75% | +22.53% | +28.80% | 73.41B |  |  | |
- Stock Market
- Stocks
- REGN Stock
- Charts Regeneron Pharmaceuticals, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
